Citadel Advisors’s Exicure XCUR Stock Holding History

Citadel Advisors’s Portfolio XCUR Stock Details XCUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,632	Closed	-$10.9K	–	15558
2024 Q1	$10.9K	Buy	+3,632	New	+$11.3K	﹤0.01%	13436
2023 Q4	–	Sell	-4,177	Closed	-$15K	–	15379
2023 Q3	$15K	Sell	4,177 -5,894	-59%	-$27.5K	﹤0.01%	12843
2023 Q2	$66K	Buy	+10,071	New	+$51.9K	﹤0.01%	11471
2023 Q1	–	Sell	-5,709	Closed	-$32.8K	–	15608
2022 Q4	$32.8K	Buy	+5,709	New	+$35.3K	﹤0.01%	12629
2022 Q3	–	Sell	-2,029	Closed	-$22K	–	13735
2022 Q2	$22K	Sell	2,029 -1,101	-35%	-$23.2K	﹤0.01%	12371
2022 Q1	$94K	Buy	3,130 +1,550	+98%	+$47.6K	﹤0.01%	12348
2021 Q4	$48K	Buy	1,580 +1,369	+649%	+$159K	﹤0.01%	13275
2021 Q3	$38K	Buy	211 +29	+16%	+$5.88K	﹤0.01%	13491
2021 Q2	$41K	Sell	182 -25	-12%	-$6.55K	﹤0.01%	13408
2021 Q1	$68K	Buy	+207	New	+$71.2K	﹤0.01%	12752

Other funds holding XCUR

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's XCUR Position: Q2 2024 in Review

Citadel Advisors sold out of Exicure (XCUR) in Q2 2024, closing a stake of 3,632 shares — an estimated $10.9K sold.

Citadel Advisors first reported a position in XCUR in Q1 2021 and held it in 10 quarters. The position peaked at $94K in Q1 2022. 15 funds tracked by Wall St. Rank hold XCUR as of Q2 2024.

Citadel Advisors reported no remaining Exicure position as of Q2 2024 after selling out during the quarter.
Citadel Advisors sold 3,632 Exicure shares in Q2 2024, an estimated $10.9K.
Citadel Advisors first reported a position in Exicure in Q1 2021 and held it in 10 quarters.
Citadel Advisors's Exicure position peaked at $94K in Q1 2022.
15 funds tracked by Wall St. Rank held Exicure as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.